Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| cbdMD, Inc.YCBD · Entity 8230 | Director | April 14, 2026 | April 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
cbdMD, Inc.
Report date April 14, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,145 |
Reported balance
After 2026-04-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-14 · Grant · Acquired 1,572 · Balance 4,145 F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 14, 2026 Filed Apr 17, 2026 00:15 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-012589 · rdgdoc.xml · nonDerivative · entry 1 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,145 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027. The restricted stock units were issued under the 2021 or 2025 Equity Compensation Plan as compensation to the Reporting Person for services on the Issuer's Board of Directors. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:21 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 1,572 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017865 · rdgdoc.xml · nonDerivative · entry 1 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,573 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors. Read SEC document |
| March 29, 2024 Filed Apr 3, 2024 13:01 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options (Right to Buy) · Derivative | 2,000 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001437749-24-010751 · rdgdoc.xml · derivative · entry 2 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2029-03-29 F2 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested. F3 · price: Not applicable. Read SEC document |
| March 29, 2024 Filed Apr 3, 2024 13:01 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010751 · rdgdoc.xml · nonDerivative · entry 1 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,008 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest quarterly on June 30, 2024, September 30, 2024, December 31, 2024 and March 31, 2025. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning March 29, 2024. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:29 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $0.28 | Not disclosed |
DisclosureSEC source: 0001437749-23-004158 · rdgdoc.xml · derivative · entry 2 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-02-17 F2 · security: The stock options were granted under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options are fully vested. F3 · price: Not applicable. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:29 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-004158 · rdgdoc.xml · nonDerivative · entry 1 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,250 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units are fully vested. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning February 16, 2023. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 22:33 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $0.57 | Not disclosed |
DisclosureSEC source: 0001437749-22-020197 · rdgdoc.xml · derivative · entry 2 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2027-08-09 F2 · security: The stock options were issued under the 2015 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning August 9, 2022. The issuance was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. and the options are fully vested as of the date of issuance. F3 · price: Not applicable. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 22:33 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-020197 · rdgdoc.xml · nonDerivative · entry 1 Swift Sibyl Nichole · CIK 0001942359 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,250 F1 · security: The restricted shares of common stock were issued under the 2015 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning August 9, 2022. The issuance was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The shares vested upon issuance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.